Bloomage Freda Biopharm Co.,Ltd. (Formerly Shandong Freda Biopharm Co.,Ltd.) was established in 1998 by Bloomage International Investment Group Inc. and Shandong Freda Pharmaceutical Group Corporation. For the past 20 years, the company has focused its efforts on R&D, production and sales of Sodium Hyaluronate (HA). The applications and specifications of HA vary by product and are divided into Pharmaceutical, Cosmetic, and Food grades.